← SynDRA
PF-04691502
SynDRA canonical compound SYN0024302 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PIK3CA |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
- MTOR
- PIK3CA
- PIK3CG
- PIK3CB
- PIK3CD
- PIK3R1
- PIK3R2
- PIK3R3
- PIK3R5
Mechanisms of action (all sources)
- MTOR inhibitor
- PI3K inhibitor
- Serine/threonine-protein kinase mTOR inhibitor
- PIK3R1 INHIBITOR
- PIK3CB INHIBITOR
- PIK3CG INHIBITOR
- PIK3CA INHIBITOR
- PIK3R2 INHIBITOR
- PIK3CD INHIBITOR
- PIK3R5 INHIBITOR
- PIK3R3 INHIBITOR
- MTOR MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AAK1
- PASK
- PGRMC1
- PFKP
- PEBP1
- PDXK
- PDGFRB
- PCYT1A
- PAK4
- PIM1
- PAK2
- PAICS
- OPA1
- OLA1
- NTRK1
- NQO2
- PHKG2
- PIP4K2A
- NEK9
- PRKACG
- PRKCD
- PRKCB
- PRKCA
- PRKAR2A
- PRKAG2
- PRKAG1
- PRKACB
- PIP4K2C
- PRKACA
- PRKAA1
- PLK4
- PKN2
- PKN1
- PKMYT1
- NLK
- NEK7
- ABL1
- MAPK14
- MAPKAPK2
- MAPK9
Cross-references
Synonyms
- PF-4691502
- PF 04691502
- UNII-4W39NS61KI
- 4W39NS61KI
- 2-amino-8-((1r,4r)-4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one
- CHEMBL1234354
- PF04691502
- 2-Amino-8-[trans-4-(2-Hydroxyethoxy)cyclohexyl]-6-(6-Methoxypyridin-3-Yl)-4-Methylpyrido[2,3-D]pyrimidin-7(8h)-One
- 2-Amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one
- NSC760536
- GTPL7936
- SMR004702782
- NCGC00381752-02
- SCHEMBL29447277
- CS-0919
- NCGC00381752-06
- US8633204, 286
- s2743
- RefChem:909600
- 4tv3
- BDBM50380313
- orb1300936
- BDBM50607921
- T6251
- HMS3656B21
- NSC-800846
- BRD-K07310275-001-02-5
- EBC-221078
- EX-A032
- SDCCGSBI-0654438.P001
- NCGC00346659-01
- AKOS005266645
- AC-28429
- DA-76758
- AKOS030257531
- GLXC-90023
- NCGC00346659-12
- SCHEMBL1381425
Look up PF-04691502 in the interactive SynDRA portal →